How Does the Market View Option Care Health?

This afternoon we watched Option Care Health rise 1.4% to a price of $28.77 per share. The mid-cap Medical Care Facility company is now trading -24.94% below its average target price of $38.33. Analysts have set target prices ranging from $37 to $40 per share for Option Care Health, and have given the stock an average rating of buy.

The stock has an average amount of shares sold short at 4.4%, and a short ratio of 5.64. Since 14.69% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 83.1% of Option Care Health's shares being owned by this investor type.

Institutions Invested in Option Care Health

Holder Shares Date Reported Percentage Value
FMR, LLC 19,738,359 2022-06-29 11% $548,528,996
Blackrock Inc. 15,897,128 2022-06-29 9% $441,781,187
Vanguard Group, Inc. (The) 14,121,852 2022-06-29 8% $392,446,267
Price (T.Rowe) Associates Inc 9,389,438 2022-06-29 5% $260,932,482
Park West Asset Management LLC 4,827,679 2022-06-29 3% $134,161,199
State Street Corporation 4,476,389 2022-06-29 2% $124,398,850
Ubs Asset Management Americas Inc 3,964,086 2022-06-29 2% $110,161,949
Marshall Wace LLP 3,933,573 2022-06-29 2% $109,313,993
Bellevue Group AG 2,887,259 2022-06-29 2% $80,236,927
Nuveen Asset Management 2,700,290 2022-06-29 1% $75,041,059

Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Option Care Health.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.